Published in Med Care on December 01, 2012
Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health (2013) 1.01
Cancer vaccines and immunotherapeutics: challenges for pricing, reimbursement and market access. Hum Vaccin Immunother (2012) 0.87
The Bayesian model on human papillomavirus vaccination in Italy lacks transparency. Med Care (2013) 0.83
Transparency or proper study valuation procedures missed? Med Care (2013) 0.75
Impact of HPV vaccination: health gains in the Italian female population. Popul Health Metr (2017) 0.75
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy. Cost Eff Resour Alloc (2017) 0.75
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst (2008) 6.13
Assessment of fracture risk. Osteoporos Int (2004) 5.15
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst (2005) 3.64
International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res (2002) 3.14
Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol (2011) 3.11
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. J Clin Oncol (2008) 2.82
Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein. Bioorg Med Chem Lett (2005) 2.80
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol (2009) 2.80
Clinical practice. Vitiligo. N Engl J Med (2009) 2.72
Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Econ Policy Law (2009) 2.65
Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol (2008) 2.56
Concern Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A (2003) 2.52
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med (2010) 2.47
Spatial and spatio-temporal models with R-INLA. Spat Spatiotemporal Epidemiol (2013) 2.26
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res (2005) 2.21
New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol (2009) 2.16
Postoperative pain after conventional laparoscopy and laparoendoscopic single site surgery (LESS) for benign adnexal disease: a randomized trial. Fertil Steril (2011) 2.04
Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res (2003) 2.04
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies. Eur J Cancer (2010) 2.03
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study. J Clin Oncol (2004) 1.95
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res (2006) 1.89
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PLoS One (2009) 1.80
Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int (2003) 1.76
Whither trial-based economic evaluation for health care decision making? Health Econ (2006) 1.73
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. Gynecol Oncol (2011) 1.71
Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology (2008) 1.70
Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clin Cancer Res (2006) 1.67
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.64
The Grossman model after 40 years. Eur J Health Econ (2012) 1.62
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood (2006) 1.60
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res (2007) 1.57
Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood (2002) 1.57
UVA-induced modification of catalase charge properties in the epidermis is correlated with the skin phototype. J Invest Dermatol (2006) 1.53
Conservative mastectomies. Aesthetic Plast Surg (2009) 1.52
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival. Gynecol Oncol (2005) 1.52
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience. Ann Surg Oncol (2010) 1.50
A prospective study of laparoscopy versus minilaparotomy in the treatment of uterine myomas. J Minim Invasive Gynecol (2005) 1.48
Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer. Eur J Cancer (2013) 1.48
Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol (2008) 1.47
Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability. Oncogene (2004) 1.46
Minilaparotomy in early stage endometrial cancer: an alternative to standard and laparoscopic treatment. Gynecol Oncol (2002) 1.45
Laparoendoscopic single-site surgery (LESS) for ovarian cyst enucleation: report of first 3 cases. Fertil Steril (2009) 1.44
Functional properties of cells obtained from human cord blood CD34+ stem cells and mouse cardiac myocytes in coculture. Am J Physiol Heart Circ Physiol (2008) 1.42
Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer. Acta Cytol (2006) 1.42
Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proced Online (2001) 1.40
Population ageing and health care expenditure: a school of 'red herrings'? Health Econ (2007) 1.39
Incidence and risk factors for clinical failure of uterine leiomyoma embolization. Obstet Gynecol (2012) 1.39
Some criticism about postoperative pain after adnexal surgery performed by single-port versus standard laparoscopy. Fertil Steril (2012) 1.39
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol (2007) 1.37
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial. J Clin Oncol (2011) 1.36
Inequalities in the provision of cardiovascular screening to people with severe mental illnesses in primary care: cohort study in the United Kingdom THIN Primary Care Database 2000-2007. Schizophr Res (2011) 1.35
Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol (2003) 1.34
Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res (2003) 1.32
Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology (2004) 1.30
The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. Br J Ophthalmol (2012) 1.30
Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region. Gene (2007) 1.29
Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol (2004) 1.29
p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem (2010) 1.28
Targeting CD133 antigen in cancer. Expert Opin Ther Targets (2009) 1.26
Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet (2010) 1.25
A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res (2006) 1.25
Syphilis Infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol (2012) 1.25
Modulation of antioxidant defense in Aspergillus parasiticus is involved in aflatoxin biosynthesis: a role for the ApyapA gene. Eukaryot Cell (2008) 1.25
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob (2009) 1.24
Measuring willingness-to-pay for risk reduction: an application of conjoint analysis. Health Econ (2002) 1.24
CD133 antigen expression in ovarian cancer. BMC Cancer (2009) 1.23
Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother (2010) 1.23
Melanins and melanogenesis: methods, standards, protocols. Pigment Cell Melanoma Res (2013) 1.23
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology (2007) 1.22
A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther (2002) 1.22
Preferences for health insurance and health status: does it matter whether you are Dutch or German? Eur J Health Econ (2010) 1.22
Treatment of melasma. J Am Acad Dermatol (2006) 1.21
The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance. Cancer Res (2005) 1.20
Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci (2002) 1.20
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance. Mol Pharmacol (2003) 1.20
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol (2006) 1.19
BRCA1-related malignancies in a family presenting with von Recklinghausen's disease. Gynecol Oncol (2002) 1.19
MiR-200c and HuR in ovarian cancer. BMC Cancer (2013) 1.18
Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol (2006) 1.17
Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res (2009) 1.17
Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer. J Cell Physiol (2012) 1.15
Reversion to susceptibility of a carbapenem-resistant clinical isolate of Klebsiella pneumoniae producing KPC-3. J Antimicrob Chemother (2013) 1.15
Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Serv Res (2012) 1.14
Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol (2010) 1.14
Laparoendoscopic single-site surgery for the treatment of benign adnexal disease: a prospective trial. Diagn Ther Endosc (2010) 1.14
Risk adjustment in health insurance and its long-term effectiveness. J Health Econ (2010) 1.14
Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology (2005) 1.13
Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res (2009) 1.13
Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J Biol Chem (2007) 1.12
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol (2008) 1.12
Molecular mechanisms of patupilone resistance. Cancer Res (2008) 1.11
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. Surg Endosc (2014) 1.10
Spatial and spatio-temporal models with R-INLA. Spat Spatiotemporal Epidemiol (2013) 1.10